|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$22,712,016 |
|
|
Indirect Value
|
$63,973 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$22,775,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-03 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
125,367 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-07 |
4 |
OE |
$77.31 |
$328,568 |
D/D |
4,250 |
125,367 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-07 |
4 |
AS |
$152.88 |
$649,740 |
D/D |
(4,250) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-10-27 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
119,077 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-10-27 |
4 |
AS |
$141.41 |
$905,598 |
D/D |
(6,290) |
116,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-10-31 |
4 |
AS |
$142.18 |
$10,860,645 |
D/D |
(75,000) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-11-06 |
4 |
AS |
$148.17 |
$629,723 |
D/D |
(4,250) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-11-06 |
4 |
OE |
$77.31 |
$328,568 |
D/D |
4,250 |
46,202 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-11-15 |
4 |
AS |
$147.29 |
$32,551 |
D/D |
(221) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-11-15 |
4/A |
AS |
$147.29 |
$7,070 |
D/D |
(48) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-11 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
46,202 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-11 |
4 |
AS |
$159.00 |
$675,750 |
D/D |
(4,250) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-16 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
44,077 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-16 |
4 |
AS |
$158.28 |
$336,345 |
D/D |
(2,125) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-24 |
4 |
AS |
$169.00 |
$1,515,761 |
D/D |
(8,969) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-24 |
4 |
OE |
$86.52 |
$795,522 |
D/D |
8,969 |
50,921 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-02 |
4 |
OE |
$91.05 |
$196,304 |
D/D |
2,156 |
44,108 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-02 |
4 |
AS |
$169.42 |
$365,270 |
D/D |
(2,156) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-05 |
4 |
OE |
$77.31 |
$792,413 |
D/D |
8,500 |
50,452 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-05 |
4 |
AS |
$163.08 |
$1,386,180 |
D/D |
(8,500) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
20,573 |
62,525 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-12 |
4 |
AS |
$150.78 |
$1,042,833 |
D/D |
(6,824) |
55,701 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-13 |
4 |
AS |
$151.40 |
$614,001 |
D/D |
(4,044) |
51,657 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-04-16 |
4 |
AS |
$163.01 |
$346,396 |
D/D |
(2,125) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-04-16 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
48,877 |
0 |
- |
|
192 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|